SARS-CoV-2 (COVID-19) en gestación y placenta: una revisión narrativa sobre el estado del arte

Felipe Troncoso; Carlos Escudero

Abstract

In Chile, the COVID-19 pandemic, a disease induced by infection with SARS-CoV-2, has caused more than 25,000 deaths. More than 370,000 women between 15 and 44 years have been detected with the infection. The greater vulnerability of pregnant women has been reported, mainly related to a higher risk for severe or critical COVID-19, with an increased incidence of adverse obstetrics and perinatal outcomes. It is relevant to consider that a high percentage of pregnant women infected with SARS-CoV-2 are asymptomatic for COVID-19, which indicates that specific effects of the virus during pregnancy may not be evident from clinical observation. The presence of SARS-CoV-2 in the placenta has been demonstrated, associating placental infection with vascular alterations that could affect utero-placental flow. On the other hand, vertical transmission to the fetus is rare but feasible. This manuscript summarizes the evidence available to date on the main effects of COVID-19 in pregnancy, emphasizing studies about the impact of SARS-CoV-2 in the placenta. This review aims to promote this issue, highlighting that several questions need to be addressed, considering the effect this pandemic could have on gestational health.

Más información

Título según SCOPUS: SARS-CoV-2 (COVID-19) in pregnancy and placenta: A narrative review on state of the art
Título según SCIELO: SARS-CoV-2 (COVID-19) en gestación y placenta: una revisión narrativa sobre el estado del arte
Título de la Revista: Revista Chilena de Obstetricia y Ginecologia
Volumen: 86
Número: 4
Editorial: Sociedad Chilena de Obstetricia y Ginecologia
Fecha de publicación: 2021
Página final: 432
Idioma: Spanish
DOI:

10.24875/RECHOG.M21000022

Notas: SCIELO, SCOPUS